Latest News and Press Releases
Want to stay updated on the latest news?
-
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If...
-
SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN Sika stärkt die Position in Zentralasien mit der Gründung einer neuen Ländergesellschaft in Kirgisistan. Mit...
-
SIKA EXPANDS ITS ACTIVITIES IN CENTRAL ASIA WITH A NEW NATIONAL SUBSIDIARY IN KYRGYZSTAN Sika is strengthening its position in Central Asia by establishing a new national subsidiary in Kyrgyzstan....
-
LONDON, 21 Apr. 2026 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
-
Addis Ababa, Ethiopia, April 20, 2026 (GLOBE NEWSWIRE) -- The African Union Commission and the International Dialogue Centre - KAICIID signed a Memorandum of Understanding at the African Union...
-
Dubai, UAE , April 20, 2026 (GLOBE NEWSWIRE) -- Pepeto confirmed this week that closing Binance listing work is moving ahead. The presale has not slowed once, wallet count doubled in the last month,...
-
NINGDE, China, April 20, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today announced...
-
LAS VEGAS, NV, April 20, 2026 (GLOBE NEWSWIRE) -- LAS VEGAS, NV - April 20, 2026 - - Kung Fu Thai & Chinese Restaurant has announced comprehensive menu updates that provide detailed...
-
FDA 授予 Daretabart (hu1418K322A) 快速通道认定资格,以解决高危神经母细胞瘤领域存在的重大未满足医疗需求,允许该药物进入加速评审和滚动审评流程FDA 通过新药临床研究 (IND) 申请后,即可在高危神经母细胞瘤复发及难治性患者中启动 SHINE II/III 期临床试验Daretabart (hu1418K322A) 第一个商业化规模 GMP...
-
Dubai, UAE, April 20, 2026 (GLOBE NEWSWIRE) -- Crypto news on the Pepeto presale shows the total raised crossed $9.3 million at a pace few presales have matched, and the holders are forming one of...